Ruibing Z. Chen
Tianjin, 300072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Proteomic and Metabolomic Analysis of Immune-Related Adverse Events in Patients Treated with PD-1 Inhibitors.
Journal: Journal of proteome research
Published: May 15, 2026
Evolution in single-cell proteomics drives new frontiers in cancer biology and precision medicine.
Journal: Cancer biology & medicine
Published: April 28, 2026
Gene-level gut microbiome signatures as predictive biomarkers for response to immune checkpoint inhibitors across multiple cancer types.
Journal: Gut microbes
Published: April 24, 2026
CDI-DTI: A Strong Cross-Domain Interpretable Drug-Target Interaction Prediction Framework Based on Multi-Strategy Fusion.
Journal: Journal of chemical information and modeling
Published: February 17, 2026
Pan-cancer Distant Metastasis Prediction Based on Graph Neural Network.
Journal: Interdisciplinary sciences, computational life sciences
Published: November 12, 2025
High-Performance Olfactory Receptor-Derived Peptide Biosensor for Acetic Acid Gas Detection Based on Polystyrene Microsphere Templates.
Journal: ACS sensors
Published: October 31, 2025
TCN-RDP: Predicting Drug-Induced Liver Injury from Time-Series Toxicogenomic Data.
Journal: Journal of chemical information and modeling
Published: October 07, 2025
Integrative mass spectrometry-driven multi-omics and single cell technologies in ankylosing spondylitis: insights into pathogenesis, biomarker discovery, and precision medicine.
Journal: Journal of translational autoimmunity
Published: August 24, 2025
Profiling of SFTS virus and host protein interactions by affinity purification-mass spectrometry.
Journal: Molecular immunology
Published: July 31, 2025
Sample preparation optimization for metabolomics and lipid profiling from a single plasma and liver tissue based on NMR and UHPLC-MS.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 28, 2025
YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression.
Journal: Cell death & disease
Published: June 10, 2025
Last Updated: 09/26/2026